Faculty Information - Fuminori Tatsumi

（Last updated : 2022-04-12 16:32:22）

Fuminori Tatsumi
Department Kawasaki Medical School Kawasaki Medical School, Department of General Internal Medicine 1,

Position Assistant Professor

■ Journal

1.	2019/09	Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: A retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus
2.	2019/04	Idiopathic and isolated adrenocorticotropic hormone deficiency presenting as continuous epigastric discomfort without symptoms of hypoglycemia: a case report.
3.	2019/03	Verification of Kumamoto Declaration 2013 and Glycemic Targets for Elderly Patients with Diabetes in Japan for prevention of diabetic complications: A retrospective longitudinal study using outpatient clinical data.
4.	2019/01	Effect of mild exercise on glycemic and bodyweight control in Japanese type 2 diabetes patients: A retrospective analysis.
5.	2019/01	Effect of mild exercise on glycemic and bodyweight control in Japanese type 2 diabetes patients: A retrospective analysis.
6.	2019/01	Eicosapentaenoic acid/arachidonic acid ratio and weight loss during hospitalization for glycemic control among overweight Japanese patients with type 2 diabetes: a retrospective observational study.
7.	2018/11	Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study
8.	2018/08	There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study.
9.	2018/06	Onset of type 1 diabetes mellitus and heparin-induced thrombocytopenia in a patient with Basedow's disease and idiopathic thrombocytopenic purpura: Novel combination as autoimmune polyglandular syndrome.
10.	2018/06	Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension.
11.	2018/05	Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis.
12.	2018/01	Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus.
13.	2017/09	Increase of cortisol / ACTH ratio after chronic treatment with liraglutide in subjects with type 2 diabetes mellitus.
14.	2017/08	Werner Syndrome and Diabetes Mellitus Accompanied by Adrenal Cortex Cancer.
15.	2017/06	Hypoglycemic Coma Induced by the Use of Succinic Acid Cibenzoline in Frail Late-stage Elderly Subjects.
16.	2017/05	Advanced breast cancer in a relatively young man with severe obesity and type 2 diabetes mellitus.
17.	2017/03	Temporal lobe epilepsy associated with GAD autoimmunity.
18.	2016/11	Association of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus.
19.	2016/11	Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalacia
20.	2016/11	Human serum albumin: Possible cause of insulin autoimmune syndrome.
21.	2016/09	Strawberry milk-like blood in a subject with diabetic lipemia: dramatic change to transparent color after insulin therapy.
22.	2016/08	Clinical effects of liraglutide are possibly influenced by hypertriglyceridemia and remaining pancreatic beta-cell function in subjects with type 2 diabetes mellitus.
23.	2016/07	Case of disseminated pyomyositis in poorly controlled type 2 diabetes mellitus with diabetic ketoacidosis.
24.	2016/07	Optimal cut-off value of alanine aminotransferase level to precisely estimate the presence of fatty liver in patients with poorly controlled type2 diabetes.
25.	2016/05	Case of iliopsoas abscess that was markedly recovered after percutaneous and surgical drainage in a patient with poorly controlled type 2 diabetes.
26.	2015/08	Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)
27.	2015/07	Pseudoaldosteronism induced by Yokukansan in an elderly Japanese type 2 diabetes mellitus patient with Alzheimer's disease.
28.	2015/06	Anti-hypertensive azelnidipine preserves insulin signaling and glucose uptake against oxidative stress in 3T3-L1 adipocytes
29.	2015	A case of disseminated pyomyositis in poorly controlled type 2 diabetes with diabetic ketoacidosis.
30.	2015	Case of iliopsoas abscess which was markedly recovered after percutaneous and surgical drainage in a subject with poorly controlled type 2 diabetes.
31.	2015	Optimal cut-off value of ALT level to precisely estimate the presence of fatty liver in subjects with poorly controlled type 2 diabetes.
32.	2013/05	Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.
33.	2013/05	Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.
34.	2013/02	Vildagliptin preserves the mass and function of pancreatic cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
35.	2013/02	Vildagliptin preserves the mass and function of pancreatic cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
36.	2012/02	Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival.
37.	2012/02	Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival.
38.	2010/05	[Role of glycemic control on preventing diabetic macroangiopathy and its therapeutic guidance].
39.	2009/09	Gallbladder edema in type 1 diabetic patient due to delayed-type insulin allergy.
40.	2009/09	Gallbladder edema in type 1 diabetic patient due to delayed-type insulin allergy.
41.	2009/08	Molecular Analysis of db Gene-related Pancreatic beta Cell Dysfunction; Evidence for a Compensatory Mechanism Inhibiting Development of Diabetes in the db Gene Heterozygote.
42.	2009/08	Molecular Analysis of db Gene-related Pancreatic beta Cell Dysfunction; Evidence for a Compensatory Mechanism Inhibiting Development of Diabetes in the db Gene Heterozygote.
Display 5 items
Display all(42)

■ Presentation

1.	2017/06/09	SGLT2-Inhibitor Shows a Kidney-Protection Effect through Ketone Body Increase （Abstract Only）
2.	2011/07/23	Antioxidative effect of azelnidpine ameliorates insulin sensitivity of 3T3-L1 adipocytes （Poster notice，General）
3.	2011/07/23	Antioxidative effect of azelnidpine ameliorates insulin sensitivity of 3T3-L1 adipocytes （Poster notice，General）
4.	2011/06/25	Ablation of PDK1 in vascular endothelial cells deteriorates systemic insulin sensitivity and angiogenesis of skeletal muscles in STZ-induced hyperglycemic mice （Poster notice）
5.	2011/06/25	Ablation of PDK1 in vascular endothelial cells deteriorates systemic insulin sensitivity and angiogenesis of skeletal muscles in STZ-induced hyperglycemic mice （Poster notice）
6.	2010/06	Molecular Mechanism of Antihypertensive Azelnidipine-Induced Augmention of Insulin Sensitivity: Evidence for Antioxidative Effect on Insulin Target 3T3-L1 Cells （Poster notice）
7.	2010/06	Molecular Mechanism of Antihypertensive Azelnidipine-Induced Augmention of Insulin Sensitivity: Evidence for Antioxidative Effect on Insulin Target 3T3-L1 Cells （Poster notice）
8.	2009/11	The strict control of hyperglycemia in the early stage of diabetes is important in maintaining long-term glycemic control -from a longitudinal analysis for 8 years- （Speech，General）
9.	2009/11	The strict control of hyperglycemia in the early stage of diabetes is important in maintaining long-term glycemic control -from a longitudinal analysis for 8 years- （Speech，General）
10.	2009/06	Ablation of Vascular Endothelial PDK1 in Diabetic db/db Mice Further Deteriorates Insulin Sensitivity through Defects of Angiogenensis in Skeletal Muscle and Adipose Tissue （Poster notice，General）
11.	2009/06	Ablation of Vascular Endothelial PDK1 in Diabetic db/db Mice Further Deteriorates Insulin Sensitivity through Defects of Angiogenensis in Skeletal Muscle and Adipose Tissue （Poster notice，General）
Display 5 items
Display all(11)

■ Belonging society

1.	2003/04～	The Japanese Society of Internal Medicine
2.	2005/05～	Japan Diabetes Society
3.	2007/04～	The Japan Endocrine Society
4.	2011/05～	Japanese Society of Hypertension
5.	2014～	Japan Hormonal Steroid Sosciety
6.	2014/04～	Japan Thyroid Association
7.	2014/06	Japan Atherosclerosis Society
8.	2015/07～	Japan Society for Medical Education
9.	2016/03～	American Diabetes Association
Display 5 items
Display all(9)